General Infectious Disease News Articles

Infectious Dis.

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Terness P et al. - The authors describe the first clinical application of MMC-treated monocyte-enriched donor cells in an attempt to control the rejection of a haploidentical stem cell transplant in a sensitized recipient and discuss the pros and cons of using MMC-treated antigen-presenting cells for tolerance induction. Although many questions remain, MMC-treated cells are a promising clinical tool for controlling allograft rejection and deleterious immune responses in autoimmune diseases.

Today in Vaccine/Immunotherapy...keeping you current

Evidence of Bias in Studies of Influenza Vaccine Effectiveness in Elderly Patients
The Journal of Infectious Diseases, 12/18/09

A Novel Influenza A (H1N1) Vaccine in Various Age Groups
New England Journal of Medicine, 12/17/09

Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine
New England Journal of Medicine, 12/17/09